Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LeishBlock

Financiado

Cerrado

LEISHBLOCK: Exploring an antileishmanial drug toolbox for blocking pathogen tran...

LEISHBLOCK: Exploring an antileishmanial drug toolbox for blocking pathogen transmission in the sand fly vector. The main objective of LEISHBLOCK is identifying antileishmanial compounds exhibiting minimal mortality to sand flies for exploitation as potential transmission blocking agents.Sand flies are the vectors responsible for transmittin... ver más

31/10/2027

Presupuesto desconocido

Líder del proyecto

UNIVERZITA KARLOVA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-11-01

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

AGL2013-46981-R NUEVOS AVANCES EN LA ENTOMOLOGIA, EPIDEMIOLOGIA Y CONTROL DE... 76K€ Cerrado

VCVCL Vector Control for Visceral and Cutaneous Leishmaniasis 15K€ Cerrado

VCVCL Vector Control for Visceral and Cutaneous Leishmaniasis 168K€ Cerrado

NEPHIMLEI Neuroendocrine regulation of Phlebotomus perniciosus immunit... 166K€ Cerrado

LeVec Molecular characterization of insecticide resistance and tra... 153K€ Cerrado

ReMVeC How has the rapid scale up of malaria control in Africa impa... 1M€ Cerrado

Duración del proyecto: 35 meses Fecha Inicio: 2024-11-01
Fecha Fin: 2027-10-31

Líder del proyecto

UNIVERZITA KARLOVA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The main objective of LEISHBLOCK is identifying antileishmanial compounds exhibiting minimal mortality to sand flies for exploitation as potential transmission blocking agents.Sand flies are the vectors responsible for transmitting Leishmania parasites, the causative agents of a range of disfiguring to lethal diseases known as leishmaniasis, affecting populations worldwide.Currently, with no human vaccines, disease control relies on reducing contact with the vector and chemotherapy. However, the effectiveness of leishmaniasis-vector control, which includes non-specific insecticide spraying, insecticide-impregnated nets, and environmental management, lags behind other disease-vector-control approaches. Moreover, treatment options for leishmaniasis are limited and often require prolonged hospitalization.To address this pressing public health issue, there is an urgent need to harness existing knowledge on the biology of these parasites, utilize available resources, and explore novel approaches to disease control.Recently, a promising transmission blocking intervention (TBI) has been pursued for vector-borne diseases like malaria, focusing on targeting parasites within the insect vector with a parasiticide. This innovative approach has demonstrated the potential to become a valuable addition to the arsenal of TBIs and merits attention in the field of leishmaniasis.Compounds will be firstly screened using sand fly and bee cell lines. Then, the safest compounds will be individually tested on the respective adult insects. The leading compounds demonstrating greater safety will be assessed for their efficacy in reducing parasite burden in Leishmania-infected sand flies, employing an innovative DNA barcoding approach.The knowledge gained from this multidisciplinary project will contribute to the discovery of urgently needed new drugs to combat this neglected and important emerging vector borne disease, while building on the research profile of the leading investigator.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores